Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.65 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.65 |
| ▸ | HTR2B | P41595 | 1/20 | 0.65 |
| ▸ | TACR1 | P25103 | 7/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.41 |
| ▸ | GBA1 | P04062 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11141618 | 0.81 | SLC6A2 (0.61) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 | |
| SCHEMBL20105596 | 0.81 | SLC6A2 (0.61) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 | |
| Hydrochloric Acid SCHEMBL15922321 | 0.79 | SLC6A2 (0.59) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 | |
| Hydrochloric Acid SCHEMBL15921747 | 0.79 | SLC6A2 (0.59) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 | |
| Hydrochloric Acid SCHEMBL15921749 | 0.79 | SLC6A2 (0.59) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 | |
| SCHEMBL28526425 | 0.79 | SLC6A2 (0.44) | SLC6A2SLC6A3ADRA1AHTR2BSLC18A3 | |
| SCHEMBL3458744 | 0.78 | SLC6A2 (0.62) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 | |
| Phenmetrazine SCHEMBL15154744 | 0.78 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 | |
| Phenmetrazine SCHEMBL8094204 | 0.78 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 | |
| Phenmetrazine SCHEMBL15159760 | 0.78 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BTACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115784474-A | High-temperature-resistant high-pressure-resistant phosphorus-free sodium-free or low-sodium scale and corrosion inhibitor for boiler and preparation method and application thereof | 上海聚焓能源科技有限公司 | 2023-03-14 | — | — | CN | claimed |
| US-4803200-A | SHIPPING FEVER SYNDROME | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-02-07 | — | — | US | claimed |
| CN-115784474-A | High-temperature-resistant high-pressure-resistant phosphorus-free sodium-free or low-sodium scale and corrosion inhibitor for boiler and preparation method and application thereof | 上海聚焓能源科技有限公司 | 2023-03-14 | — | — | CN | disclosed |
| EP-2569310-A1 | MORPHOLINE COMPOUNDS AS MINERALOCORTICOID RECEPTOR ANTAGONISTS | Pfizer Inc (US) | 2013-03-20 | — | — | EP | disclosed |
| US-20110281854-A1 | MORPHOLINE COMPOUNDS | PFIZER INC | 2011-11-17 | — | — | US | disclosed |
| WO-2011141848-A1 | MORPHOLINE COMPOUNDS AS MINERALOCORTICOID RECEPTOR ANTAGONISTS | PFIZER INC. (US) | 2011-11-17 | — | — | WO | disclosed |
| US-4803200-A | SHIPPING FEVER SYNDROME | A. H. ROBINS COMPANY, INCORPORATED (US) | 1989-02-07 | — | — | US | disclosed |
| US-4384968-A | TREATING GAS STREAM WITH MORPHOLINE OR SERIVATIVE | BETZ LABORATORIES, INC. (US) | 1983-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110281854-A1 | MORPHOLINE COMPOUNDS | REN, MC2R, NR3C2 | SLC6A2 966/4885SLC6A3 1447/4885ADRA1A 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.